14.182 makale bulundu

Oleuropein regulates neuronal survival and Histone acetylation in Parkinson's disease: cellular and epigenetic insights.

Singh R, Rathore AS, Shah A, Keshri PK, Dilnashin H, Gupta NK, Satyaprakash SA, Singh S, Chaturvedi CP, Singh SP.

Metab Brain Dis · 2026-07-31

DOI: 10.1007/s11011-026-01945-2PMID: 42536231

Synükleinopatilerde REM uyku davranış bozukluğunun farmakolojik tedavileri: etkinliğin ve güvenliğin sistematik bir incelemesi.

Pharmacological treatments of REM sleep behaviour disorder in synucleinopathies: a systematic review of effectiveness and safety.

Byun JJ, Badrakalimuthu VR.

Sleep Med · 2026-07-31

DOI: 10.1016/j.sleep.2026.109154PMID: 42623795

The Clinical, Genetic, Psychosocial, and Care Landscape of X-Linked Dystonia-Parkinsonism in Filipino Men: A Scoping Review.

Ramos MD, Manning J, Harris J, Adorno M, Marye R, Evangelista L.

Am J Mens Health · 2026-07-30

DOI: 10.1177/15579883261467125PMID: 42531151

Evaluation of genetic instability in patients with amyotrophic lateral sclerosis.

Souza HJBC, Souza KM, Dos Santos MB, Silva MAP, Grassi TF, Destro MV, Braz MG.

Mutat Res Genet Toxicol Environ Mutagen · 2026-07-30

DOI: 10.1016/j.mrgentox.2026.503953PMID: 42580784

Dilasyonlu Kardiyomiyopati ve Nörolojik Bozukluklar Arasındaki Genetik Üstesinden Gelme: Bir Sonraki Nesil Dizileme Çalışmasının Öngörüleri.

Genetic Overlap Between Dilated Cardiomyopathy and Neurological Disorders: Insights from a Next-Generation Sequencing Study.

Salluzzo MG, Schillaci FA, Zago E, Fucile S, Marcolungo L, Schinocca P, Lanza G, Ferri R, Leonardi G, Salemi M.

Diagnostics (Basel) · 2026-07-30

DOI: 10.3390/diagnostics16152395PMID: 42587631

Seboreik Dermatit ve Parkinson Hastalığı Arasında Genetik, Lipid, Fungal Mikrobiyom ve Nöroinflamatuar Bağlantılar: Bir Anlatı İncelemesi.

Genetic, Lipid, Fungal Microbiome and Neuroinflammatory Links Between Seborrheic Dermatitis and Parkinson's Disease: A Narrative Review.

Kefala V, Oikonomou E, Sfyri E, Grech VS, Tertipi N, Andreou E, Rallis E.

Genes (Basel) · 2026-07-30

DOI: 10.3390/genes17080894PMID: 42650087

Duodenal alfa-Sinüklein PFF Enjeksiyonu C57BL/6J ve A53T Transgenik Farelerde Vagus-İlgili Gut-Beyin Patolojisi'ni indükler.

Duodenal α-Synuclein PFF Injection Induces Vagus-Related Gut-to-Brain Pathology in C57BL/6J and A53T Transgenic Mice.

Wang M, Sun G, Wan P, Wang Z, Nie Y, Liu H, Geng M, Liu M, Zhang Y.

Brain Sci · 2026-07-30

DOI: 10.3390/brainsci16080804PMID: 42651119

Brain-specific PP1/LRRK2 interaction-targeting peptides as a novel strategy for Parkinson’s disease treatment

Loisel S, Petit F, Auregan G, Guillermier M, Benfissa M, Gipchtein P, Mohamed AT, Posnograjeva K, Teesalu T, Badin RA, Rebollo A.

· 2026-07-29

DOI: 10.64898/2026.07.27.740889

Çevre sensörü olarak DNMT1: çevresel maruziyetleri, seks hormonu sinyalizasyonunu ve nörogelişimsel ve nörodejeneratif hastalıklara karşı savunmasızlığı bağlayan epigenetik yollar.

DNMT1 as an environmental sensor: epigenetic pathways linking environmental exposures, sex hormone signaling, and vulnerability to neurodevelopmental and neurodegenerative diseases.

Vöhringer K, Müller MS, Yildiz CB, Zimmer-Bensch G.

Front Neurol · 2026-07-29

DOI: 10.3389/fneur.2026.1883887PMID: 42591225

LRRK2 G2019S, bağlama bağımlı ana bilgisayar savunma sonuçlarını sürmek için doğuştan gelen ve uyarlanabilir bağışıklığı yeniden programlamaktadır.

LRRK2 G2019S reprograms innate and adaptive immunity to drive context-dependent host defense outcomes.

Merchak AR, Herrick MK, Houser MC, Moustafa DA, Goldberg JB, Boss JM, Kohlmeier J, Cook DM, Keating CE, Chang J, West AB, Tansey MG.

Front Cell Neurosci · 2026-07-29

DOI: 10.3389/fncel.2026.1860967PMID: 42591263

Integrated In Vivo and In Vitro Analysis of Alpha-Synuclein Aggregation and Neuroinflammatory Amplification in a Composite Parkinson's Disease Model.

He X, Qi H, Ma Z, Lv M, Gao S, Mei C, Yin J.

Neurochem Res · 2026-07-29

DOI: 10.1007/s11064-026-04840-5PMID: 42525302

Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson's disease.

Meloni M, Agliardi C, Salvatore A, Saibene FL, Marano M, Castagna A, Arcuri P, Zanzottera M, Guerini FR, Clerici M.

NPJ Parkinsons Dis · 2026-07-28

DOI: 10.1038/s41531-026-01474-wPMID: 42649220